Mr. Michael Martinz reports

KANEH BOSM ANNOUNCES DTC ELIGIBILITY

Kaneh Bosm Biotechnology Inc. has secured eligibility by the Depository Trust Company (DTC) for its shares on the OTC Markets. DTC is a subsidiary of the Depository Trust & Clearing Corp. (DTCC) that manages the electronic clearing and settlement of publicly traded companies in the United States.

Further to the company's news release dated Aug. 14, 2018, Kaneh Bosm's common shares are now fully DTC eligible and trade under the symbol KNHBF on the OTC Markets. Securities that are eligible to be electronically cleared and settled through the DTC are considered DTC eligible. This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors.

Kaneh Bosm's chief executive officer, Eugene Beukman, stated: "We are very pleased to have obtained DTC eligibility. This status will make the process of trading our stock in the United States much easier. We expect that this will make our shares available to a larger percentage of the investment market, which should improve the liquidity of our shares and therefore benefit Kaneh Bosm and our shareholders."

We seek Safe Harbor.